Metformin monotherapy for adults with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Metformin monotherapy for adults with type 2 diabetes mellitus

Published:2020-06-05 Issue:6 Volume:2020 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Gnesin Filip¹,Thuesen Anne Cathrine Baun²³,Kähler Lise Katrine Aronsen⁴,Madsbad Sten⁵,Hemmingsen Bianca⁶

Affiliation:

1. Department of Endocrinology, Diabetes and Metabolism; Department 7652, Rigshospitalet; Copenhagen Denmark

2. Steno Diabetes Center Copenhagen; Gentofte Denmark

3. Faculty of Health and Medical Sciences, University of Copenhagen; Novo Nordisk Foundation Center for Basic Metabolic Research; Copenhagen Denmark

4. Faculty of Health and Medical Sciences; University of Copenhagen; Copenhagen N Denmark

5. Department of Endocrinology; Hvidovre Hospital, University of Copenhagen; Hvidovre Denmark

6. Cochrane Metabolic and Endocrine Disorders Group; Institute of General Practice, Medical Faculty of the Heinrich-Heine-University Düsseldorf; Düsseldorf Germany

Publisher

Wiley

Subject

Pharmacology (medical)

Reference262 articles.

1. Rosiglitazone decreases bone mineral density and increases bone turnover in postmenopausal women with type 2 diabetes mellitus;Bilezikian;Journal of Clinical Endocrinology and Metabolism,2013

2. Mechanism of action study to evaluate the effect of rosiglitazone on bone in postmenopausal women with type 2 diabetes mellitus: rationale, study design and baseline characteristics;Fitzpatrick;Journal of Drug Assessment,2012

3. Evaluation of quantitative computed tomography cortical hip quadrant in a clinical trial With rosiglitazone: a potential new study endpoint;Miller;Journal of Clinical Densitometry: Assessment & Management of Musculoskeletal Health,2016

4. Study in postmenopausal women with type 2 diabetes looking at approved diabetes drugs and how they affect bone health clinicaltrials.gov/ct2/show/NCT00679939

5. Effects of rosiglitazone vs metformin on circulating osteoclast and osteogenic precursor cells in postmenopausal women with type 2 diabetes mellitus;Rubin;Journal of Clinical Endocrinology and Metabolism,2014

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The evidence base of the 10 most prescribed drugs in England, France, and the United States: a scoping review;Journal of Clinical Epidemiology;2024-10

2. Advances in small-molecule insulin secretagogues for diabetes treatment;Biomedicine & Pharmacotherapy;2024-09

3. Arzneitherapie des Diabetes mellitus Typ 2 – ist Metformin neuerdings verzichtbar?;Die Innere Medizin;2024-08-21

4. Effect of different hypoglycemic drugs and insulin on the risk of new-onset atrial fibrillation in people with diabetes: a network meta-analysis;European Journal of Medical Research;2024-07-31

5. Long-term effects of different hypoglycemic drugs on carotid intima-media thickness progression: a systematic review and network meta-analysis;Frontiers in Endocrinology;2024-05-31